507 related articles for article (PubMed ID: 1824791)
1. Characterization of a thromboxane A2/prostaglandin H2 receptor in guinea pig lung membranes using a radioiodinated thromboxane mimetic.
Saussy DL; Mais DE; Dubé GP; Magee DE; Brune KA; Kurtz WL; Williams CM
Mol Pharmacol; 1991 Jan; 39(1):72-8. PubMed ID: 1824791
[TBL] [Abstract][Full Text] [Related]
2. Characterization of thromboxane A2/prostaglandin H2 binding sites in guinea pig cardiac membrane preparations.
Bowling N; Dubé GP; Kurtz WL; Brune KA; Saussy DL; Dorn GW; Mais DE
J Mol Cell Cardiol; 1994 Jul; 26(7):915-23. PubMed ID: 7966360
[TBL] [Abstract][Full Text] [Related]
3. Platelet and vascular thromboxane A2/prostaglandin H2 receptors. Evidence for different subclasses in the rat.
Masuda A; Mais DE; Oatis JE; Halushka PV
Biochem Pharmacol; 1991 Jul; 42(3):537-44. PubMed ID: 1830482
[TBL] [Abstract][Full Text] [Related]
4. Binding of a novel radioiodinated thromboxane A2/prostaglandin H2 antagonist to guinea pig lung membranes.
Saussy DL; Clark PD; Gunn DL; Mais DE; Froelich LL
Eicosanoids; 1992; 5(1):1-4. PubMed ID: 1419073
[TBL] [Abstract][Full Text] [Related]
5. 7-[(1R,2S,3S,5R)-6,6-dimethyl-3-(4- iodobenzenesulfonylamino)bicyclo[3.1.1]hept-2-yl]-5(Z)-heptenoic acid: a novel high-affinity radiolabeled antagonist for platelet thromboxane A2/prostaglandin H2 receptors.
Naka M; Mais DE; Morinelli TA; Hamanaka N; Oatis JE; Halushka PV
J Pharmacol Exp Ther; 1992 Aug; 262(2):632-7. PubMed ID: 1386885
[TBL] [Abstract][Full Text] [Related]
6. Differential effect of pH on thromboxane A2/prostaglandin H2 receptor agonist and antagonist binding in human platelets.
Mayeux PR; Morinelli TA; Williams TC; Hazard ES; Mais DE; Oatis JE; Baron DA; Halushka PV
J Biol Chem; 1991 Jul; 266(21):13752-8. PubMed ID: 1830308
[TBL] [Abstract][Full Text] [Related]
7. Binding of an 125I-labeled thromboxane A2/prostaglandin H2 receptor antagonist to washed canine platelets.
Mais DE; Kochel PJ; Saussy DL; Halushka PV
Mol Pharmacol; 1985 Aug; 28(2):163-9. PubMed ID: 2991736
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the vascular thromboxane A2/prostaglandin endoperoxide receptor in rabbit aorta. Regulation by dexamethasone.
Sessa WC; Halushka PV; Okwu A; Nasjletti A
Circ Res; 1990 Dec; 67(6):1562-9. PubMed ID: 2147131
[TBL] [Abstract][Full Text] [Related]
9. Distinct platelet thromboxane A2/prostaglandin H2 receptor subtypes. A radioligand binding study of human platelets.
Dorn GW
J Clin Invest; 1989 Dec; 84(6):1883-91. PubMed ID: 2531760
[TBL] [Abstract][Full Text] [Related]
10. Characterization of an 125I-labeled thromboxane A2/prostaglandin H2 receptor agonist.
Morinelli TA; Oatis JE; Okwu AK; Mais DE; Mayeux PR; Masuda A; Knapp DR; Halushka PV
J Pharmacol Exp Ther; 1989 Nov; 251(2):557-62. PubMed ID: 2530338
[TBL] [Abstract][Full Text] [Related]
11. Binding of a radioiodinated agonist to thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptors in guinea pig lung membranes.
Mais DE; Saussy DL; Magee DE; Williams CM
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():347-50. PubMed ID: 1825567
[No Abstract] [Full Text] [Related]
12. Characterization of thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptors of rat platelets and their interaction with TXA2/PGH2 receptor antagonists.
Hanasaki K; Arita H
Biochem Pharmacol; 1988 Oct; 37(20):3923-9. PubMed ID: 2973322
[TBL] [Abstract][Full Text] [Related]
13. Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to washed human platelets.
Mais DE; Burch RM; Saussy DL; Kochel PJ; Halushka PV
J Pharmacol Exp Ther; 1985 Dec; 235(3):729-34. PubMed ID: 3001275
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of ligand binding to thromboxane A2/prostaglandin H2 receptors by diethylpyrocarbonate. Protection by receptor ligands and reversal by hydroxylamine.
Schrör K; Davis-Bruno K; Halushka PV
Biochem Pharmacol; 1995 Mar; 49(7):921-7. PubMed ID: 7741764
[TBL] [Abstract][Full Text] [Related]
15. Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to guinea-pig platelets.
Halushka PV; Mais DE; Garvin M
Eur J Pharmacol; 1986 Nov; 131(1):49-54. PubMed ID: 3816947
[TBL] [Abstract][Full Text] [Related]
16. Androgen regulation of thromboxane A2/prostaglandin H2 receptor expression in human erythroleukemia cells.
Matsuda K; Mathur RS; Duzic E; Halushka PV
Am J Physiol; 1993 Dec; 265(6 Pt 1):E928-34. PubMed ID: 8279549
[TBL] [Abstract][Full Text] [Related]
17. Cyclic oxidation-reduction reactions regulate thromboxane A2/prostaglandin H2 receptor number and affinity in human platelet membranes.
Dorn GW
J Biol Chem; 1990 Mar; 265(8):4240-6. PubMed ID: 2137820
[TBL] [Abstract][Full Text] [Related]
18. In vitro characterization of a novel TXA2/PGH2 receptor ligand (S-145) in platelets and vascular and airway smooth muscle.
Dubé GP; Mais DE; Jakubowski JA; Brune KA; Utterback BG; True TA; Rinkema LE; Kurtz WL
J Pharmacol Exp Ther; 1992 Aug; 262(2):784-91. PubMed ID: 1386888
[TBL] [Abstract][Full Text] [Related]
19. Thromboxane binding and signal transduction in rat glomerular mesangial cells.
Spurney RF; Onorato JJ; Albers FJ; Coffman TM
Am J Physiol; 1993 Feb; 264(2 Pt 2):F292-9. PubMed ID: 8447439
[TBL] [Abstract][Full Text] [Related]
20. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets.
Yin K; Halushka PV; Yan YT; Wong PY
J Pharmacol Exp Ther; 1994 Sep; 270(3):1192-6. PubMed ID: 7932171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
